Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.65 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15337804 | 1.00 | KMT2A (0.65) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| SCHEMBL14600741 | 0.82 | KMT2A (0.54) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| SCHEMBL22222120 | 0.80 | KMT2A (0.46) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| SCHEMBL28911345 | 0.76 | ADRA2C (0.56) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| Mebicar SCHEMBL1465373 | 0.74 | ADRA2C (1.00) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| Mebicar SCHEMBL15685069 | 0.74 | ADRA2C (1.00) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| SCHEMBL21414055 | 0.74 | KMT2A (0.46) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| SCHEMBL14924207 | 0.72 | KMT2A (0.44) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| SCHEMBL8902606 | 0.71 | KMT2A (0.57) | KMT2AMEN1PABPC1ADRA2CTSHR | |
| SCHEMBL12667575 | 0.71 | MEN1 (0.39) | KMT2AMEN1PABPC1ADRA2CTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5618951-A | REACTING A CHLORODIFLUOROACETATE WITH A HALOSILANE USING AN UREA SILVENT AND A REDUCING AGENT | ELI LILLY AND COMPANY (US) | 1997-04-08 | — | — | US | claimed |
| CN-112292198-B | Composite hollow fiber membrane, method for producing same, hollow fiber membrane cartridge comprising same, and fuel cell membrane humidifier | 可隆工业株式会社 | 2023-04-04 | — | — | CN | disclosed |
| US-10429753-B2 | Electrophotographic photoconductor, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2019-10-01 | — | — | US | disclosed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | disclosed |
| US-9760030-B2 | Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-09-12 | — | — | US | disclosed |
| US-20170102627-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2017-04-13 | — | — | US | disclosed |
| US-9599917-B2 | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus | CANON KABUSHIKI KAISHA (JP) | 2017-03-21 | — | — | US | disclosed |
| US-RE45994-E1 | Electrolytic capacitor and its manufacturing method | PANASONIC CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| EP-0938108-B1 | Electrolytic capacitor and its manufacturing method | PANASONIC CORP (JP) | 2015-04-08 | — | — | EP | disclosed |
| US-8962233-B2 | Actinic-ray—or radiation-sensitive resin composition and method of forming pattern using the composition | FUJIFILM CORPORATION (JP) | 2015-02-24 | — | — | US | disclosed |
| EP-0938108-A2 | Electrolytic capacitor and its manufacturing method | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1999-08-25 | — | — | EP | disclosed |
| US-5618951-A | REACTING A CHLORODIFLUOROACETATE WITH A HALOSILANE USING AN UREA SILVENT AND A REDUCING AGENT | ELI LILLY AND COMPANY (US) | 1997-04-08 | — | — | US | disclosed |
| EP-0299164-B2 | PROCESS FOR THE PREPARATION OF 2,2-PARACYCLOPHANE | UNION CARBIDE CORPORATION (US) | 1993-04-21 | — | — | EP | disclosed |
| EP-0291889-B1 | Process for the preparation of dichloro-[2,2] paracyclophane | UNION CARBIDE CORPORATION (US) | 1992-09-02 | — | — | EP | disclosed |
| US-5110903-A | Films, coatings for electronic applications | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1992-05-05 | — | — | US | disclosed |
| EP-0299164-B1 | PROCESS FOR THE PREPARATION OF 2,2-PARACYCLOPHANE | UNION CARBIDE CORPORATION (US) | 1990-09-19 | — | — | EP | disclosed |
| US-4849559-A | HOFMANN ELIMINATION OF 2/3)-CHLORO-P-METHYL-BENZYLTRIMETHYLAMMONIUM HYDROXIDE | UNION CARBIDE CORPORATION (US) | 1989-07-18 | — | — | US | disclosed |
| EP-0299164-A1 | Process for the preparation of 2,2-paracyclophane | UNION CARBIDE CORPORATION (US) | 1989-01-18 | — | — | EP | disclosed |
| EP-0291889-A1 | Process for the preparation of dichloro-[2,2] paracyclophane | UNION CARBIDE CORPORATION (US) | 1988-11-23 | — | — | EP | disclosed |
| US-4769505-A | Process for the preparation of the parylene dimer | UNION CARBIDE CORPORATION (US) | 1988-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | KMT2A 3974/4885MEN1 1056/4885PABPC1 2029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.